Direxion Daily S&P Biotech Bull 3X Shares (LABU)
NYSEARCA: LABU · Real-Time Price · USD
69.35
-0.95 (-1.35%)
Aug 29, 2025, 4:00 PM - Market closed
LABU Holdings Information
LABU is an equity ETF with a total of 136 individual holdings. The top holdings are S&P Biotechnology Select Industry Index Swap stock at 18.60%, Dreyfus Govt Cash Man Ins at 14.91%, Goldman Sachs Fin Gov 465 Institut at 10.38%, Goldman Sachs Sterling FixInc Port at 10.13%, and Dreyfus Trsry Securities Cash Mgmt at 3.13%.
Total Holdings
136
Top 10 Percentage
66.49%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
652.89M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | n/a | S&P Biotechnology Select Industry Index Swap | 18.60% |
2 | n/a | Dreyfus Govt Cash Man Ins | 14.91% |
3 | n/a | Goldman Sachs Fin Gov 465 Institut | 10.38% |
4 | n/a | Goldman Sachs Sterling FixInc Port Inc | 10.13% |
5 | n/a | Dreyfus Trsry Securities Cash Mgmt | 3.13% |
6 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.15% |
7 | INSM | Insmed Incorporated | 1.94% |
8 | HALO | Halozyme Therapeutics, Inc. | 1.92% |
9 | INCY | Incyte Corporation | 1.74% |
10 | REGN | Regeneron Pharmaceuticals, Inc. | 1.60% |
11 | NBIX | Neurocrine Biosciences, Inc. | 1.57% |
12 | UTHR | United Therapeutics Corporation | 1.56% |
13 | ABBV | AbbVie Inc. | 1.53% |
14 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.53% |
15 | GILD | Gilead Sciences, Inc. | 1.47% |
16 | BMRN | BioMarin Pharmaceutical Inc. | 1.45% |
17 | BIIB | Biogen Inc. | 1.45% |
18 | BBIO | BridgeBio Pharma, Inc. | 1.43% |
19 | AMGN | Amgen Inc. | 1.39% |
20 | NTRA | Natera, Inc. | 1.38% |
21 | EXEL | Exelixis, Inc. | 1.31% |
22 | MRNA | Moderna, Inc. | 1.28% |
23 | VRTX | Vertex Pharmaceuticals Incorporated | 1.21% |
24 | EXAS | Exact Sciences Corporation | 1.18% |
25 | ROIV | Roivant Sciences Ltd. | 1.04% |
As of Aug 27, 2025